AR064602A1 - Nebulizador anticonceptivo oral - Google Patents

Nebulizador anticonceptivo oral

Info

Publication number
AR064602A1
AR064602A1 ARP070105558A ARP070105558A AR064602A1 AR 064602 A1 AR064602 A1 AR 064602A1 AR P070105558 A ARP070105558 A AR P070105558A AR P070105558 A ARP070105558 A AR P070105558A AR 064602 A1 AR064602 A1 AR 064602A1
Authority
AR
Argentina
Prior art keywords
nebulizer
oral contraceptive
formulation
mouth
salt
Prior art date
Application number
ARP070105558A
Other languages
English (en)
Inventor
Der Voort Maarschalk Kees Van
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of AR064602A1 publication Critical patent/AR064602A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Formulacion anticonceptiva líquida para la administracion transmucosal en la boca. La formulacion comprende etonogestrel, opcionalmente junto con etinilestradiol, pero no contiene un formador de matriz o un promotor de absorcion percutánea, el cual es un ácido hidroxi o una sal de él.
ARP070105558A 2006-12-12 2007-12-12 Nebulizador anticonceptivo oral AR064602A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06125961 2006-12-12

Publications (1)

Publication Number Publication Date
AR064602A1 true AR064602A1 (es) 2009-04-15

Family

ID=38521609

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105558A AR064602A1 (es) 2006-12-12 2007-12-12 Nebulizador anticonceptivo oral

Country Status (10)

Country Link
US (1) US20100105641A1 (es)
EP (1) EP2120874A2 (es)
AR (1) AR064602A1 (es)
CA (1) CA2671469A1 (es)
CL (1) CL2007003592A1 (es)
MX (1) MX2009006316A (es)
PE (1) PE20081403A1 (es)
SG (1) SG144065A1 (es)
TW (1) TW200840595A (es)
WO (1) WO2008071429A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009101182A1 (en) * 2008-02-15 2009-08-20 N.V. Organon Use of etonogestrel for benign prostate hyperplasia (bph).

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
ATE288255T1 (de) * 1996-04-12 2005-02-15 Novadel Pharma Inc Polares bukkales spray
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
US6506742B2 (en) * 1999-12-13 2003-01-14 Ortho-Mcneil Pharmaceutical, Inc. Soluble contraceptive liquid formulation
WO2003068315A1 (en) * 2002-02-15 2003-08-21 Pantarhei Bioscience B.V. A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males
WO2004054544A1 (fr) * 2002-12-10 2004-07-01 Besins International Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant un progestatif et un oestrogene, son procede de preparation et ses utilisations

Also Published As

Publication number Publication date
WO2008071429A3 (en) 2008-10-09
WO2008071429A2 (en) 2008-06-19
MX2009006316A (es) 2009-06-23
PE20081403A1 (es) 2008-10-04
CL2007003592A1 (es) 2008-06-20
US20100105641A1 (en) 2010-04-29
EP2120874A2 (en) 2009-11-25
CA2671469A1 (en) 2008-06-19
TW200840595A (en) 2008-10-16
SG144065A1 (en) 2008-07-29

Similar Documents

Publication Publication Date Title
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
EP2248519A3 (en) Non-mucoadhesive film dosage forms
CL2011001621A1 (es) Composicion farmaceutica oral de liberacion sostenida que comprende en una forma de dosificacion unitaria, una matriz hidrofilica, un opioide, una sal de un aine, y opcionalmente un surfactante aniónico; y uso para preparar medicamentos utiles en la prevencion, alivio o disminución del nivel del dolor y supresión de la tos.
AR059174A1 (es) Formas farmaceuticas en forma de pelicula para usar en la cavidad bucal (obleas)
EP3311801A3 (en) Chewable gelled emulsions
MX2010005385A (es) Medicamentos topicos para la terapia antimicotica.
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
RS52367B (en) GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES
AR058163A1 (es) Medicamentos exhaltadores del deseo sexual que comprenden derivados de benzimidazolona
GT201000144A (es) " composiciones farmaceuticas "
BRPI0507897A (pt) formulação de droga sólida
ATE474561T1 (de) Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin
PE20080400A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
GT200600157A (es) Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo
CL2007003643A1 (es) Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.
SV2008002466A (es) Oblea que contiene hormonas esteroides ref. p-sv-79.953/gh
PE20130147A1 (es) Combinacion farmaceutica de teobromina y un agente antitusivo no opioide
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
AR064602A1 (es) Nebulizador anticonceptivo oral
RS20050618A (en) Use of dipyridamole in combination with acetylsalicylic acid and an ngiotensin ii antagonist for stroke prevention
GT200800208A (es) Composición farmacèutica que comprende la combinación de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia.
AR059577A1 (es) Agente de aceleracion de absorcion del calcio
AR080541A1 (es) Tratamiento para la endometriosis
DE60312642D1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
CL2008002485A1 (es) Uso de gestagenos en combinacion con (6s)-5-metiltetrahidrofolato para el tratamiento de la endometriosis con reduccion de los efectos colaterales terapeuticos; procedimiento de preparacion de una composicion farmaceutica que comprende a dichos compuestos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure